164
Participants
Start Date
September 30, 2008
Primary Completion Date
November 30, 2010
Study Completion Date
December 31, 2010
Levocarnitine tartrate
Capsule form, 1,002 mg (3 capsules) taken by mouth two times per day (morning and evening). L-carnitine will be taken from Day 0 to Day 180.
cilostazol
"Background therapy beginning at 50mg (1 pill) taken by mouth two times per day for two to three weeks. Then 100 mg (1 pill) to be taken by mouth two times per day (morning and evening) for one to two weeks.~Randomized therapy will consist of 100 mg (1 pill) to be taken by mouth two times per day (morning and evening) for approximately 180 days."
University of Rochester Medical Center, Rochester
HPV Heart, PA, Columbia
Durham VA-Medical Center, Durham
Pensacola Research Consultants, Inc., Pensacola
Meridian Research, St. Petersburg
DMI Healthcare Group, Inc., Pinellas Park
Radiant Research, Inc, Columbus
Jobst Vascular Center, Toledo
Beloit Clinic Research Office, Beloit
Ochsner Medical Center, New Orleans
Central Arkansas Veteran's Healthcare System, Little Rock
Peripheral Vascular Associates, San Antonio
Clinical Trials of Texas, Inc., San Antonio
Aurora Denver Cardiology Associates, Aurora
Aurora Denver Cardiology Associates, Denver
Radiant Research- Salt Lake City, Salt Lake City
Internal Medicine Physicians Associates, Phoenix
Tatum Ridge Internal Medicine, Phoenix
Apex Research Institute, Santa Ana
VA Palo Alto Health Care System, Palo Alto
University of California at Davis Vascular Center, Sacramento
Sacramento Heart and Vascular Research Center, Sacramento
University of Massachusetts Medical Center, Worcester
Dartmouth-Hitchcock Medical Center, Lebanon
Collaborators (1)
Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
Colorado Prevention Center
OTHER